Amlodipine AND Atorvastatin

JUN 25, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Amlodipine AND Atorvastatin (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling for a fixed-dose combination of amlodipine and atorvastatin; this is a regulatory action, not a clinical evidence report, and does not contain trial outcomes or efficacy data.